Major Events - Yuan Da Zhu Gong (02163) plans to apply for bankruptcy reorganization at Changsha Intermediate People's Court [1] - Yi Li Holdings (00076) subsidiary intends to issue blockchain vouchers V76, redeemable for bulk commodities on the platform [1] - Peijia Medical-B (09996): National Medical Products Administration accepts registration application for GeminiOne® transcatheter edge-to-edge repair system [1] - Paggen Biopharmaceutical-B (02565) proposes to grant exclusive license for VISEPEGENATIDE (PB-119) in the Middle East and Africa [1] - Beijing Enterprises Environment Group (00154) bids for Hong Kong I·PARK 2 project [1] - Fangda Holdings (01521) plans to acquire Shanghai Guanhua Medical Technology Co., Ltd. for 270 million yuan to enhance global laboratory service capabilities [1] - Lianzhong (06899) focuses on female user value, driving new entertainment through content [1] - Global New Materials International (06616) increases stake in CQV to 50.75%, strengthening global business collaboration [1] - Qianxin Biotechnology-B (02509): Qianxin's industrialization base successfully passes EU QP audit [1] - China Energy Construction (03996) subsidiary signs three new energy general contracting agreements, totaling approximately 19.554 billion yuan [1] - Yongyi International (01218) plans to sell all issued shares of Zhuoyi to Gaoshan (00616) [1] - Bohai Bank (09668) plans to list high capital-occupying debt assets for sale, with an initial pricing of no less than 48.883 billion yuan [1] - Chuangsheng Holdings (02680) plans to receive a premium of about 6% for full acquisition offer, resuming trading on October 13 [1] - Kelun-Botai Biopharmaceutical (06990): Core product TROP2ADC, Lukan-Satuzi (SAC-TMT) approved by National Medical Products Administration for third indication, treating EGFR mutation non-small cell lung cancer after EGFR-TKI progression [1] Operating Performance - Zhaojin Mining (01818) reports net profit of approximately 2.117 billion yuan for the first three quarters, a year-on-year increase of 140.43% [2] - Sunny Optical Technology (02382): September mobile phone camera module shipments reach 48.524 million units, a month-on-month increase of 15.3% and a year-on-year increase of 32% [2] - Yuexiu Property (00123) reports cumulative contract sales of approximately 79.812 billion yuan for the first nine months, a year-on-year increase of about 2.8% [2] - Qiu Tai Technology (01478) reports September camera module sales of 46.654 million units, a month-on-month decrease of 7.6% but a year-on-year increase of 45.1% [2]

格隆汇10月10日丨沛嘉医疗-B(09996.HK)发布公告，公司近日已收到国家药品监督管理局("国家药监 局")的确认函，确认其已受理GeminiOne®经导管缘对缘修复("TEER")系统的注册申请。 GeminiOne®是公司内部研发的创新TEER装置。其独特的滑槽式机械结构在保持较小植入物尺寸及输送 系统的同时，实现了更长的夹合臂长。其他创新之处包括能够降低手术复杂性的独立瓣叶抓捕功能，可 防止手术过程中的重复锁定及解锁的自动锁定机制及能够适应更广泛解剖结构的多角度解脱设计。 ...

GeminiOne®是本公司内部研发的创新TEER装置。其独特的滑槽式机械结构在保持较小植入物尺寸及输 送系统的同时，实现了更长的夹合臂长。其他创新之处包括能够降低手术复杂性的独立瓣叶抓捕功能， 可防止手术过程中的重复锁定及解锁的自动锁定机制及能够适应更广泛解剖结构的多角度解脱设计。 智通财经APP讯，沛嘉医疗-B(09996)发布公告，本公司近日已收到中国国家药品监督管理局(国家药监 局)的确认函，确认其已受理GeminiOne® 经导管缘对缘修复(TEER)系统的注册申请。 ...